COM:CUREVAC
CureVac
- Stock
Last Close
2.56
22/11 21:00
Market Cap
697.59M
Beta: -
Volume Today
473.83K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 4.57M - | 10.36M 126.59% | 35.34M 241.04% | 40.07M 13.38% | |||
average payables | 7.18M - | 11.48M 59.85% | 69.94M 509.42% | 95.25M 36.19% | |||
average receivables | 12.27M - | 9.75M 20.52% | 10.16M 4.19% | 28.97M 185.06% | |||
book value per share | 0.18 - | -0.24 233.41% | 3.94 1,720.58% | 3.70 6.10% | 2.82 23.80% | ||
capex per share | -0.08 - | -0.07 16.97% | -0.26 277.73% | -0.69 162.04% | -0.49 28.29% | ||
capex to depreciation | -3.89 - | -1.71 56.18% | -4.44 160.06% | -8.16 83.89% | -3.93 51.88% | ||
capex to operating cash flow | 0.20 - | 0.14 29.24% | -0.09 164.48% | 0.17 292.47% | 0.33 86.72% | ||
capex to revenue | -1.14 - | -0.70 38.64% | -0.97 37.96% | -1.24 28.25% | -1.38 11.34% | ||
cash per share | 0.34 - | 0.18 46.99% | 7.34 3,920.35% | 4.39 40.25% | 2.65 39.69% | ||
days of inventory on hand | 60.70 - | 80.83 33.16% | 374.22 362.96% | 86.06 77.00% | 47.59 44.70% | ||
days payables outstanding | 185.73 - | 69.54 62.56% | 453.85 552.69% | 187.35 58.72% | 135.38 27.74% | ||
days sales outstanding | 194.48 - | 370.66 90.59% | 13.60 96.33% | 65.58 382.20% | 213.50 225.57% | ||
debt to assets | 0.00 - | 0.61 34,988.45% | 0.02 96.71% | 0.02 25.30% | 0.05 96.08% | ||
debt to equity | 0.01 - | -1.85 27,439.53% | 0.04 102.29% | 0.04 0.78% | 0.08 88.07% | ||
dividend yield | |||||||
earnings yield | -0.01 - | -0.01 37.18% | -0.01 5.59% | -0.07 580.44% | -0.23 219.21% | ||
enterprise value | 8.57B - | 8.83B 3.02% | 10.73B 21.51% | 4.85B 54.77% | 614.10M 87.35% | ||
enterprise value over ebitda | -127.78 - | -96.50 24.48% | -97.71 1.26% | -12.56 87.15% | -2.75 78.08% | ||
ev to operating cash flow | -115.65 - | -101.54 12.21% | 20.54 120.23% | -6.62 132.23% | -2.15 67.58% | ||
ev to sales | 665.92 - | 506.99 23.87% | 219.41 56.72% | 47.12 78.52% | 9.11 80.67% | ||
free cash flow per share | -0.50 - | -0.56 11.66% | 2.63 567.02% | -4.63 275.84% | -2.01 56.65% | ||
free cash flow yield | -0.01 - | -0.01 9.25% | 0.04 449.86% | -0.15 486.64% | -0.36 132.54% | ||
graham net net | -0.15 - | -0.71 374.54% | 2.96 516.71% | 2.09 29.43% | 1.14 45.62% | ||
graham number | 1.29 - | 1.76 36.76% | 7.96 351.91% | 13.58 70.46% | 9.14 32.66% | ||
income quality | 1.04 - | 0.87 16.64% | -4.02 563.21% | 1.78 144.18% | 1.15 35.37% | ||
intangibles to total assets | 0.05 - | 0.04 11.77% | 0.01 78.54% | 0.01 22.11% | 0.04 223.12% | 0 100% | |
interest coverage | -264.81 - | -68.15 74.27% | -5.61 91.77% | -39.88 610.82% | -67.29 68.75% | ||
interest debt per share | 0.00 - | 0.46 16,283.74% | 0.29 36.87% | 0.21 27.08% | 0.24 14.84% | ||
inventory turnover | 6.01 - | 4.52 24.90% | 0.98 78.40% | 4.24 334.86% | 7.67 80.83% | ||
invested capital | 0.01 - | -1.85 27,439.53% | 0.04 102.29% | 0.04 0.78% | 0.08 88.07% | ||
market cap | 8.59B - | 8.78B 2.20% | 12.02B 36.90% | 5.64B 53.12% | 1.07B 81.05% | ||
net current asset value | -20.51M - | -116.25M 466.89% | 589.85M 607.41% | 470.25M 20.28% | 256.81M 45.39% | ||
net debt to ebitda | 0.32 - | -0.53 266.17% | 11.77 2,322.47% | 2.02 82.80% | 2.03 0.44% | ||
net income per share | -0.40 - | -0.57 40.19% | -0.72 26.02% | -2.21 209.46% | -1.32 40.49% | ||
operating cash flow per share | -0.42 - | -0.49 17.34% | 2.89 685.76% | -3.94 236.15% | -1.51 61.60% | ||
payables turnover | 1.97 - | 5.25 167.10% | 0.80 84.68% | 1.95 142.25% | 2.70 38.38% | ||
receivables turnover | 1.88 - | 0.98 47.53% | 26.84 2,625.47% | 5.57 79.26% | 1.71 69.28% | ||
research and ddevelopement to revenue | 3.24 - | 2.48 23.40% | 2.33 6.26% | 7.92 240.39% | 0.93 88.29% | ||
return on tangible assets | -0.60 - | -0.80 34.05% | -0.09 89.22% | -0.36 317.09% | -0.30 16.43% | ||
revenue per share | 0.07 - | 0.10 35.31% | 0.27 173.79% | 0.55 104.33% | 0.36 35.60% | ||
roe | -2.22 - | 2.33 205.08% | -0.18 107.78% | -0.60 229.57% | -0.47 21.91% | ||
roic | -2.26 - | -1.97 12.93% | -0.16 91.87% | -0.55 245.00% | -0.40 26.76% | ||
sales general and administrative to revenue | 1.59 - | 2.42 52.70% | 0.92 61.98% | 0.85 8.05% | 1.32 55.90% | ||
shareholders equity per share | 0.18 - | -0.24 233.41% | 3.94 1,720.58% | 3.70 6.10% | 2.82 23.80% | ||
stock based compensation to revenue | -0.33 - | 1.12 440.36% | 0.29 74.08% | 0.15 50.13% | 0.14 6.19% | ||
tangible asset value | 25.87M - | -48.50M 287.48% | 697.20M 1,537.53% | 675.24M 3.15% | 501.48M 25.73% | ||
tangible book value per share | 0.15 - | -0.28 287.48% | 3.86 1,501.74% | 3.63 6.04% | 2.65 26.94% | ||
working capital | 44.94M - | 29.09M 35.27% | 1.14B 3,826.68% | 582.28M 49.02% | 427.80M 26.53% |
All numbers in (except ratios and percentages)